Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 375 of 715 entries
View as:

Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00154310 Org: User:
Start: 06/30/05 End: 09/30/08 Due: 09/30/09

Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)

Phase: N/A Priority: Normal
NCT ID: NCT00338936 Org: User:
Start: 05/31/06 End: 09/30/07 Due: 09/30/08

Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Phase: N/A Priority: Normal
NCT ID: NCT00394173 Org: User:
Start: 09/30/06 End: 10/31/07 Due: 10/31/08

Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity

Phase: N/A Priority: Normal
NCT ID: NCT00094146 Org: User:
Start: 01/31/02 End: 12/31/02 Due: 12/31/03

SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00299832 Org: User:
Start: 04/30/06 End: 05/31/07 Due: 05/31/08

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Phase: N/A Priority: Normal
NCT ID: NCT00623103 Org: User:
Start: 01/31/08 End: - Due: -

Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00239018 Org: User:
Start: 04/30/03 End: 07/31/05 Due: 07/31/06

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy

Phase: N/A Priority: Normal
NCT ID: NCT00674323 Org: User:
Start: 04/30/08 End: - Due: -

VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00171132 Org: User:
Start: 08/31/04 End: 08/31/07 Due: 08/31/08

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00942994 Org: User:
Start: 06/30/09 End: - Due: -

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Phase: N/A Priority: Normal
NCT ID: NCT00316628 Org: User:
Start: 06/30/05 End: - Due: -

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00366002 Org: User:
Start: 06/30/06 End: 09/30/07 Due: 09/30/08

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00888004 Org: User:
Start: 03/31/09 End: - Due: -

A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00426452 Org: User:
Start: 07/31/06 End: - Due: -

Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00821574 Org: User:
Start: 07/31/05 End: 03/31/07 Due: 03/31/08

Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00138619 Org: User:
Start: 11/30/04 End: 04/30/07 Due: 04/30/08

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT01042392 Org: User:
Start: 11/30/09 End: 01/31/11 Due: 01/31/12

Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00417261 Org: User:
Start: 11/30/06 End: 04/30/08 Due: 04/30/09

Real-world Aliskiren Use in Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01393860 Org: User:
Start: 12/31/10 End: - Due: -

Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01070030 Org: User:
Start: 01/31/10 End: 10/31/10 Due: 10/31/11

Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00171184 Org: User:
Start: 04/30/05 End: 06/30/06 Due: 06/30/07

Antialbuminuric Effects of Valsartan and Lisinopril

Phase: N/A Priority: Normal
NCT ID: NCT00171600 Org: User:
Start: 07/31/05 End: 01/31/07 Due: 01/31/08

Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off

Phase: N/A Priority: Normal
NCT ID: NCT00391898 Org: User:
Start: 10/31/06 End: 06/30/08 Due: 06/30/09

A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness

Phase: N/A Priority: Normal
NCT ID: NCT02271854 Org: User:
Start: 10/31/14 End: 12/31/14 Due: 12/31/15

Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

Phase: N/A Priority: Normal
NCT ID: NCT00452270 Org: User:
Start: 03/31/07 End: 04/30/07 Due: 04/30/08